Profile cover photo
Profile photo
Pharmadrome
7 followers -
Specialists in Life Sciences Recruitment
Specialists in Life Sciences Recruitment

7 followers
About
Posts

Post has attachment
An exciting career opportunity became available at a global innovative pharmaceutical company, which is looking to appoint a Market Access Manager to develop and implement most effective local market access strategies in Estonia.
Add a comment...

Post has attachment
A global medical device manufacturer is strengthening its presence in the Baltic States and is looking to appoint a Field Clinical Engineer in Lithuania, who will be responsible for providing technical support to surgeons and hospitals.
Add a comment...

Post has attachment
Family members of late Olainfarm owner Valerijs Maligins fear that the company's shareholders may suffer major losses as a result of the new management's actions.
Add a comment...

Post has attachment
Novartis is moving +Alcon Laboratories, Inc.’s headquarters from Texas to Geneva, where the company plans to employ up to 700 people.
Add a comment...

Post has attachment
Bayer is considering job cuts and outsourcing as part of a wide-ranging review of drug research and development.
Add a comment...

Post has attachment
Novartis plans to invest €78.8m in production facilities in Switzerland for cell and gene therapies after winning EU approval for Kymriah, which could create up to 450 jobs.
Add a comment...

Post has attachment
Estonia's medicinal products market has increased by 6.9% in the Q2 of 2018, reaching €80.3 million.
Add a comment...

Post has attachment
The +European Medicines Agency is expecting to lose 30% of its staff ahead of the move to Amsterdam. Initial staff surveys suggested that only 19% of staff might opt not to relocate.
Add a comment...

Post has attachment
Estonian Ministry of Justice finds that in order to increase competition, Estonia's medicines market should be liberalised to a significant degree, including by lifting the restriction on pharmacy ownership and the prohibition of vertical integration, among other changes.
Add a comment...

Post has attachment
Pfizer has decided to split into three after it failed to sell its consumer healthcare business a few months ago. The new units will come into effect at the beginning of the 2019 fiscal year and will be called Innovative Medicines, Established Medicines, and Consumer Healthcare.
Add a comment...
Wait while more posts are being loaded